Search
for

    Sort by

    Research

    30 / 1000+ results
      Complications of Subcutaneous Contraception: A Review

      research Complications of Subcutaneous Contraception: A Review

      27 citations , January 2018 in “Curēus”
      This review discusses the complications of subcutaneous contraception and emphasizes the importance of adequately counseling patients on potential side effects to aid informed decision-making; however, it reports no new clinical results.
      Hormonal Contraceptives: Pharmacology Tailored to Women's Health

      research Hormonal contraceptives: pharmacology tailored to women's health

      88 citations , June 2016 in “Human Reproduction Update”
      This review discusses developments in oral contraceptives, highlighting improved individualization, reduced side effects, and enhanced suitability for various women's health needs, but it reports no new clinical results.
      Sex Hormones and Related Compounds, Including Hormonal Contraceptives

      research Sex Hormones and Related Compounds, Including Hormonal Contraceptives

      January 2015 in “Side effects of drugs annual”
      This review discusses various sex hormones and related compounds, including estrogens and anabolic steroids, but reports no new findings; it highlights existing literature from 2014 regarding their use and effects.
      The Skin and Subcutaneous Tissues: Conditions, Diagnosis, and Systemic Implications

      research The Skin and Subcutaneous Tissues

      1 citations , January 2013 in “Springer eBooks”
      The document concludes that skin and nail changes can indicate various underlying health conditions.
      Dienogest

      research Dienogest

      64 citations , January 1998 in “Drugs”
      In this study, oral dienogest combined with ethinylestradiol provided effective contraception with a Pearl Index of approximately 0.2 and improved androgenic symptoms without significant metabolic effects.

      research Decreased allopregnanolone induced by hormonal contraceptives is associated with a reduction in social behavior and sexual motivation in female rats

      1 citations , January 2013 in “UNICA IRIS Institutional Research Information System (University of Cagliari)”
      This study found that chronic treatment with EE/LNG in female rats decreased brain concentrations of allopregnanolone, leading to reduced social and sexual behaviors; progesterone administration reversed these effects, except when finasteride was used to block the increase.
      Treatment of Hirsutism with the Pure Antiandrogen Flutamide

      research Treatment of hirsutism with the pure antiandrogen flutamide

      130 citations , September 1990 in “Journal of the American Academy of Dermatology”
      This study found that combining flutamide with an oral contraceptive significantly reduced hirsutism, acne, and seborrhea in patients after seven months, without significant side effects.
      Androgen Excess: Investigations and Management

      research Androgen excess: Investigations and management

      82 citations , May 2016 in “Best Practice & Research in Clinical Obstetrics & Gynaecology”
      This article outlines the clinical features, evaluation, and treatment strategies for androgen excess in polycystic ovary syndrome, highlighting important diagnostic and management approaches but reporting no new research results.
      Polycystic Ovary Syndrome in Adolescents

      research PCOS in adolescents

      71 citations , November 2009 in “Best Practice & Research in Clinical Obstetrics & Gynaecology”
      This article discusses the complexities of diagnosing and managing polycystic ovary syndrome in adolescents and highlights the lack of established diagnostic criteria and unclear clinical implications, without presenting new clinical findings.
      Hormonal Treatment of Acne Vulgaris: An Update

      research Hormonal treatment of acne vulgaris: an update

      46 citations , September 2016 in “Clinical, Cosmetic and Investigational Dermatology”
      This article reviews the hormonal pathogenesis and treatment strategies for acne vulgaris, particularly in women with severe or treatment-resistant cases, associating it with hormonal imbalances and hyperandrogenism.
      Antiandrogen And Hormonal Treatment Of Acne

      research ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE

      38 citations , October 1996 in “Dermatologic Clinics”
      This review discusses inflammatory and medication-related skin conditions associated with kidney disease and emphasizes the importance of timely referral to nephrology, reporting no new clinical results.
      Pharmacologic Therapy of Polycystic Ovary Syndrome

      research Pharmacologic Therapy of Polycystic Ovary Syndrome

      37 citations , February 2007 in “Clinical Obstetrics and Gynecology”
      This article examines current pharmacologic treatments for PCOS focusing on symptom-specific approaches, particularly the metabolic effects of therapies, but reports no new clinical findings.
      Antiandrogen Therapy in Dermatology

      research ANTIANDROGEN THERAPY IN DERMATOLOGY

      32 citations , November 1996 in “International Journal of Dermatology”
      This review discusses the use of antiandrogen therapy in dermatology, covering treatments for conditions like acne, hirsutism, and androgenic alopecia but reports no new clinical findings.
      Cardiovascular Risk Factors and Events in Women with Androgen Excess

      research Cardiovascular risk factors and events in women with androgen excess

      31 citations , November 2014 in “Journal of Endocrinological Investigation”
      This article reviews androgen excess and cardiometabolic risks in women, highlighting increased cardiovascular disease risk in those with polycystic ovary syndrome, but reports no new clinical results.
      Contemporary Medical Therapy for Polycystic Ovary Syndrome

      research Contemporary medical therapy for polycystic ovary syndrome

      31 citations , September 2006 in “International journal of gynaecology and obstetrics”
      This article reviews diagnostic criteria and treatment options for polycystic ovary syndrome, focusing on hormonal and metabolic management strategies, and presents no new clinical data.
      Polycystic Ovary Syndrome in Adolescence and Type 2 Diabetes

      research PCOS in Adolescence and Type 2 Diabetes

      28 citations , November 2014 in “Current Diabetes Reports”
      This review discusses the complex links between polycystic ovary syndrome, insulin resistance, and potential metabolic risks starting in adolescence, noting the need for early screening and treatment but reports no new clinical results.
      Obesity and Polycystic Ovary Syndrome

      research Obesity and the Polycystic Ovary Syndrome

      28 citations , November 2007 in “Medical Clinics of North America”
      This review discusses the impact, pathophysiology, and health risks of obesity and the metabolic syndrome in polycystic ovarian syndrome, emphasizing the potential life-saving benefits of recognition and treatment, but it reports no new results.